Then this news from 3-08 had little offsetting effect:
quote: Affymetrix Inc. AFFX announced today that Korea's National Institute of Health (NIH) and Center for Disease Control and Prevention will use the Affymetrix GeneChip(R) Human Mapping 500K Array Set for a series of groundbreaking genome-wide association studies in critical disease areas, including diabetes, hypertension, asthma and metabolic syndrome.
The joker in the deck is they're up for a prestigious award, winners announced April 3:
quote:Arlington, Va., March 8 /PRNewswire/ -- The Life Science Executive Exchange -- an online community of senior executives -- together with The Scientist (http://www.the-scientist.com/) and The Science Advisory Board (http://www.scienceboard.net) is pleased to announce the finalists of the 2006 Life Science Industry Awards. The winners will be announced at a cocktail reception on April 3 at the Renaissance Hotel in Washington, D.C.
More than 2,400 scientists from around the world were independently surveyed by leading market research firm BioInformatics, LLC (http://www.gene2drug.com). The thousands of participating scientists cast their votes for the companies that have made the greatest contributions to life science technology in the past year. As a result, the awards recognize those life science suppliers voted "best-in-class" in each of the 12 product categories, and six communications and support categories, to include:
Product Categories
-- Cell Biology Instrumentation -- Cell Biology Kits and Reagents -- Cell Culture Media, Reagents and Plasticware -- Computer Hardware -- Gene Expression Analysis Products -- High Throughput Screening and Analysis Systems -- Image Analysis Systems -- Instrumentation for Genomic Analysis -- Instrumentation for Protein Analysis -- Nucleic Acid Purification Products -- Protein Separation Products -- RNAi Products
Communication and Support Categories
-- Print Catalog -- Customer Service -- Technical Support -- Web Site -- Sales Representatives -- Print Advertisement
Although hundreds of organizations were nominated as "best-in-class", the finalists include:
Affymetrix AFFX {my emphasis} Ambion Apple AAPL Applied Biosystems ABI BD Biosciences (Becton, Dickinson and Company) BDX Beckman Coulter BEC Bio-Rad Laboratories (Amex: BIO and BIOb) Carl Zeiss Dell DELL Dharmacon (Fisher Scientific) FSH Fisher Scientific FSH GE Healthcare GE HP/Compaq (NYSE, Nasdaq: HPQ) Invitrogen IVGN Kodak Molecular Imaging Systems (Eastman Kodak) EK Molecular Devices MDCC New England Biolabs PerkinElmer Life and Analytical Sciences PKI Pierce Biotechnology (Fisher Scientific) FSH Promega Qiagen QGEN Sigma-Aldrich SIAL VWR Scientific
about: "Affymetrix, Inc. is engaged in the development, manufacture, sale and service of systems for genetic analysis for use in the life sciences and clinical healthcare. Affymetrix has developed its GeneChip system and related microarray technology as the platform of choice for acquiring, analyzing and managing complex genetic information. The integrated GeneChip platform includes disposable deoxyribonucleic acid (DNA) probe arrays (chips) consisting of nucleic acid sequences set out in an ordered, high density pattern; certain reagents for use with the probe arrays; a scanner and other instruments used to process the probe arrays, and software to analyze and manage genomic information obtained from the probe arrays. Related microarray technology also offered by Affymetrix includes instrumentation, software and licenses for fabricating, scanning, collecting and analyzing results from complementary technologies." [from msn/moneycentral]
Company has not revised its earning estimates, continues to land contracts and is up for a major award...